drugset / Trial / NCT04209530
Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women
NaSingle-groupOpen-labelTreatment
Summary
This is a single center, open-label, Phase 2a study to assess the photonumeric scale, morphological, and histopathological changes associated with Collagenase Clostridium Histolyticum (CCH) in adult women with moderate or severe Edematous Fibrosclerotic Panniculopathy (EFP).
Timeline
- Start
- 2019-11-20
- Primary completion
- 2020-07-23
- Completion
- 2020-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | 1.68 mg | — |